Welcome to our dedicated page for Safety Shot news (Ticker: SHOT), a resource for investors and traders seeking the latest updates and insights on Safety Shot stock.
Safety Shot, Inc. (symbol: SHOT) is a prominent player in the wellness and functional beverage sector. Known for its innovative and health-centric products, the company is headquartered in Jupiter, Florida. Safety Shot, Inc. initially made waves as Jupiter Wellness, Inc., specializing in the development of hemp-derived cannabidiol (CBD) products for therapeutic and medical purposes. These products targeted a variety of ailments including cancer, arthritis, anxiety, insomnia, psoriasis, and chronic pain.
The company's product portfolio includes CBD-infused sun care lotions under the Canisun brand, providing various sun protection factors. Additionally, it is developing CBD-infused skincare products under the Caniskin brand and dermatological treatments under the CanidermRx brand.
Transitioning from its CBD roots, Safety Shot, Inc. has now ventured into the functional beverage market. The company is set to launch its groundbreaking product, Safety Shot. This patented beverage is designed to help consumers feel better faster by reducing blood alcohol content and enhancing mental clarity.
In a strategic move to expand its market presence, Safety Shot, Inc. has partnered with Gopuff, a delivery service that promises to bring thousands of products to customers' doorsteps within minutes. This collaboration is aimed at making Safety Shot a household name.
For more details about their products and latest developments, visit their official website at www.drinksafetyshot.com.
Safety Shot, Inc. (Nasdaq: SHOT) has announced a strategic move to spin off its wellness consumer products segment into a separate entity called Caring Brands, Inc. This decision aims to create value for shareholders and allow Safety Shot to focus on commercializing its proprietary Safety Shot Dietary Supplement, which supports alcohol metabolism and reduces Blood Alcohol Content.
As part of the agreement, Safety Shot will receive three million shares of Caring Brands stock. The company plans to issue a dividend of two million shares to Safety Shot shareholders. Caring Brands, which develops natural-based therapeutics for conditions like hair growth, psoriasis, vitiligo, and eczema, intends to go public via an IPO within the next three months.
This separation will enable each entity to pursue its distinct strategy and business, allowing shareholders to evaluate the performance of each business independently. Caring Brands will be responsible for all costs associated with its wellness business operations moving forward.
Safety Shot (Nasdaq: SHOT) has partnered with Launchpad's All Roads Travel (ART) network to target the college student market. ART, the #1 College Tour Operator in the U.S., will help raise brand awareness for Safety Shot's product that lowers blood alcohol content in 30 minutes. The campaign will span over 100 major campuses, utilizing thousands of student ambassadors to create organic content, organize events, and manage product sampling.
With 21 million college students in the U.S. boasting $593 billion in spending power, this partnership aims to establish Safety Shot as a must-have product among this demographic. CEO Jarett Boon emphasized the potential for significant brand awareness in a market that values both fun and academic success. The collaboration leverages ART's expertise in student engagement and peer-driven marketing to build brand loyalty among college students.
Safety Shot, Inc. (Nasdaq: SHOT) has announced a Notice of Allowance for a new U.S. patent covering its latest clinically-backed formula. This patent strengthens the company's portfolio of formulations designed to rapidly reduce blood alcohol content (BAC). Safety Shot's COO, David Sandler, highlighted this as a significant milestone in the company's mission to lead a new category addressing alcohol-related problems.
The patent supports Safety Shot's competitive advantage, including faster alcohol removal, improved cognitive ability, and reduced impairment. It also allows the company to enforce specific marketplace claims and solidifies its position as a leader in rapid alcohol reduction. CEO Jarret Boon emphasized the patent's role in supporting their industry-leading clinical findings and commitment to consumer solutions.
Safety Shot, Inc. (Nasdaq: SHOT) announced that its President, Jordan Schur, has invested an additional $3.4 million in the company through his family investment group, Core 4 Capital Corp. This investment comes in the form of a private placement, with the issuance of 3,370,787 shares at $0.89 per share and 3,370,767 warrants at $0.125 per warrant. Combined with previous investments, Core 4 has now invested a total of $9.4 million in Safety Shot.
Schur expressed enthusiasm about the company's progress, citing recent clinical trial results that demonstrate Safety Shot's effectiveness in lowering Blood Alcohol Content and alleviating hangover symptoms. The company plans to use the proceeds for working capital, general corporate purposes, and to support the growth of the Safety Shot brand.
Safety Shot, Inc. (Nasdaq: SHOT) has reported groundbreaking clinical results for its rapid alcohol reducer. The double-blind, randomized, placebo-controlled study showed that Safety Shot not only significantly decreases blood alcohol content (BAC) in as little as 30 minutes but also rapidly reduces acetaldehyde in the blood, the main cause of unpleasant after-effects from heavy drinking.
The study demonstrated a substantial increase in aldehyde dehydrogenase and a marked decrease in acetaldehyde, proving that Safety Shot can effectively remove alcohol-related toxins faster than the body's natural processes. This breakthrough addresses the root cause of morning-after symptoms, which is acetaldehydes, not dehydration.
Safety Shot's patented formula is available in a 12oz drink, 4oz shot, and dry powder stick pack, positioning the company as a leader in combating alcohol's negative effects.
Safety Shot, Inc. (Nasdaq: SHOT), the company behind the world's first alcohol detoxifier, has announced a partnership with VENDO, a leading e-commerce platform. This strategic move aims to significantly boost Safety Shot's online presence and brand growth. VENDO, known for its expertise in Amazon and Walmart marketplaces, will help Safety Shot navigate the rapidly expanding e-commerce landscape, which was valued at $6.9 trillion in 2024.
Safety Shot's President, Jordan Schur, expressed enthusiasm about the partnership, highlighting VENDO's reputation as the best team in the business. VENDO CEO Darren Saul emphasized their commitment to helping Safety Shot reach a wider audience through seamless online shopping experiences across various platforms.
Safety Shot, Inc. (Nasdaq: SHOT) reported strong Q2 2024 results, with a 40% increase in sales and a 17.7% decrease in operating expenses compared to Q1. The company's recent clinical trial demonstrated significant efficacy in reducing Blood Alcohol Content (BAC), showing a 30%-50% faster rate of alcohol reduction within 30 minutes of consumption compared to placebo.
Safety Shot announced new product formats, including 4-ounce bottles launching in Q3 and a powdered version in Q4. The company also secured partnerships with Capital Drugs, expanding to 300 pharmacies nationwide, and Mr. Checkout for wider distribution. Additional partnerships include GoPuff and BevMo, enhancing market presence.
Safety Shot, Inc. (Nasdaq: SHOT) has announced significant findings from a recent clinical trial conducted at The Center for Applied Health Sciences. The study evaluated the impact of Safety Shot on Blood Alcohol Content (BAC) and demonstrated remarkable results. Within 30 minutes of consuming Safety Shot, participants showed a 30%-50% faster rate of alcohol reduction compared to the placebo group.
Key findings include:
- Consistent lowering of breath alcohol content
- Significant improvements in BAC, ethanol, acetaldehyde, and aldehyde dehydrogenase levels
- Reduced head discomfort, fatigue, and improved concentration
The study results are being prepared for peer review and publication in a biomedical journal. Safety Shot aims to revolutionize the wellness space with its innovative approach to responsible alcohol consumption.
Safety Shot, Inc. (Nasdaq: SAFS) is set to launch a powdered version of its alcohol-reducing product in early Q4. The new format, available in convenient stick packs, maintains the full efficacy of the original formula. This innovation addresses a growing market for stick packaging solutions, projected to reach $517.61 million by 2031.
The powder stick packs will be sold in packs of 6, with single stick options available at select locations. This format expansion aims to increase brand visibility, broaden the customer base, and offer greater convenience for consumers looking to reduce their blood alcohol content in as little as 30 minutes.
Safety Shot, Inc. (Nasdaq: SHOT) is set to launch a powdered version of its alcohol-reducing nutraceutical in early Q4. The product, available in convenient stick pack format, maintains 100% efficacy of the original formula. This expansion addresses the growing global stick packaging market, projected to reach $517.61 million by 2031.
The powder stick packs will be offered in packs of 6, with some locations providing single stick options. This new format aims to increase brand visibility, expand retail presence, and broaden the customer base. Safety Shot's innovative product is designed to reduce blood alcohol content in as little as 30 minutes, offering a portable solution for consumers on the go.
FAQ
What is the current stock price of Safety Shot (SHOT)?
What is the market cap of Safety Shot (SHOT)?
What does Safety Shot, Inc. do?
Where is Safety Shot, Inc. headquartered?
What was the company's previous name?
What are some of the company's other product lines?
What is the purpose of the Safety Shot beverage?
What ailments does Safety Shot, Inc.'s CBD products target?
What is Gopuff and how is it related to Safety Shot, Inc.?
How can I get more information about Safety Shot, Inc.?
Who can I contact for investor relations?
When was Safety Shot, Inc. founded?
